Parkwood LLC decreased its holdings in shares of Lam Research Corporation (NASDAQ:LRCX – Free Report) by 60.4% in the second quarter, HoldingsChannel reports. The firm owned 35,512 shares of the semiconductor company’s stock after selling 54,119 shares during the quarter. Parkwood LLC’s holdings in Lam Research were worth $15,388,000 at the end of the most recent quarter.
A number of other large investors have also recently made changes to their positions in LRCX. State Street Corp lifted its stake in Lam Research by 0.4% in the third quarter. State Street Corp now owns 59,817,352 shares of the semiconductor company’s stock worth $8,024,684,000 after acquiring an additional 265,805 shares during the period. Geode Capital Management LLC boosted its stake in shares of Lam Research by 0.4% during the 4th quarter. Geode Capital Management LLC now owns 33,747,368 shares of the semiconductor company’s stock valued at $5,764,117,000 after purchasing an additional 126,613 shares in the last quarter. Invesco Ltd. increased its position in shares of Lam Research by 7.7% during the fourth quarter. Invesco Ltd. now owns 22,821,354 shares of the semiconductor company’s stock valued at $3,906,559,000 after buying an additional 1,638,406 shares during the period. Norges Bank bought a new position in Lam Research in the fourth quarter worth about $3,645,427,000. Finally, Price T Rowe Associates Inc. MD lifted its holdings in Lam Research by 352.2% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,695,210 shares of the semiconductor company’s stock worth $2,344,347,000 after buying an additional 10,666,540 shares during the period. 84.61% of the stock is currently owned by institutional investors.
Lam Research Trading Down 0.6%
NASDAQ:LRCX opened at $312.88 on Thursday. The stock has a market cap of $391.51 billion, a price-to-earnings ratio of 54.32, a PEG ratio of 1.25 and a beta of 1.84. The company has a quick ratio of 1.91, a current ratio of 2.63 and a debt-to-equity ratio of 0.30. The company’s 50 day moving average price is $333.58 and its 200-day moving average price is $288.43. Lam Research Corporation has a 52 week low of $94.11 and a 52 week high of $438.50.
Analyst Ratings Changes
A number of research analysts have weighed in on LRCX shares. Morgan Stanley reduced their target price on Lam Research from $404.00 to $367.00 and set an “overweight” rating on the stock in a report on Thursday, July 30th. TD Cowen reaffirmed a “buy” rating and issued a $400.00 price target (up from $340.00) on shares of Lam Research in a research note on Thursday, July 9th. Citigroup reiterated a “buy” rating and issued a $450.00 price objective (up from $315.00) on shares of Lam Research in a report on Wednesday, June 17th. Seaport Research Partners began coverage on shares of Lam Research in a research report on Monday, May 4th. They issued a “buy” rating and a $300.00 target price on the stock. Finally, Mizuho lowered their price target on shares of Lam Research from $370.00 to $365.00 and set an “outperform” rating for the company in a research report on Tuesday. One research analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $357.31.
View Our Latest Stock Report on LRCX
Key Lam Research News
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: AI-focused R&D expansion: Lam Research broke ground on a 120,000-square-foot laboratory in Tualatin, Oregon, as part of a planned investment of more than $3 billion in its global lab network over the next five years. The facility is intended to support collaboration with chipmakers and accelerate equipment innovations for advanced AI semiconductors. Lam Research Oregon lab announcement
- Positive Sentiment: Strong AI demand outlook: CEO Tim Archer said increasingly complex AI models require more computing power, bandwidth and storage, creating demand for semiconductor innovation. The investment reinforces Lam’s positioning as a supplier to the AI infrastructure buildout. Lam Research AI investment video
- Positive Sentiment: Favorable analyst and fundamentals commentary: Zacks highlighted AI-driven growth, recurring services revenue, earnings momentum and Lam’s balance sheet, while Mizuho maintained an “outperform” rating despite trimming its price target to $365 from $370. Lam’s latest reported quarter also showed 30% year-over-year revenue growth and an earnings beat.
- Neutral Sentiment: Investor outreach scheduled: CFO Doug Bettinger will participate in upcoming investor conferences. The events could provide updates on demand, AI exposure and the Oregon investment, but no new financial guidance was announced. Lam Research conference announcement
- Negative Sentiment: Investment and valuation concerns: The multibillion-dollar R&D expansion will raise near-term capital and operating costs, while the stock’s high earnings multiple leaves less room for disappointment. The modest analyst price-target reduction may also have limited enthusiasm.
Insider Buying and Selling
In other news, SVP Neil J. Fernandes sold 7,659 shares of Lam Research stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $309.60, for a total value of $2,371,226.40. Following the completion of the sale, the senior vice president directly owned 58,470 shares in the company, valued at $18,102,312. The trade was a 11.58% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Abhijit Y. Talwalkar sold 18,282 shares of the firm’s stock in a transaction that occurred on Monday, July 13th. The stock was sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the completion of the sale, the director owned 87,142 shares in the company, valued at $29,192,570. This represents a 17.34% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 80,441 shares of company stock worth $27,614,296. 0.31% of the stock is owned by corporate insiders.
Lam Research Company Profile
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Read More
- Five stocks we like better than Lam Research
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
